Delivery Order SPE2DB22D2206-SPE2DB25FHD28
- Not listed
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order on July 29, 2025, for Bridion 500 mg/5 mL vials, with a ceiling value of $35,252.62 under firm fixed-price terms. The contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. This competitively awarded, non-set-aside delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Bridion 200 mg/2 mL vials totaling $2,544.38 with a completion date of August 26, 2025. This competitively awarded, non-set-aside contract reflects a firm fixed-price delivery order structure, with performance to be executed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The award represents a child order under AmerisourceBergen's substantial Indefinite Delivery...
- The Defense Logistics Agency awarded a $1,095.66 delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Bridion 200 mg/2 mL vials. This firm fixed-price delivery order, which is expected to be completed by September 4, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The award was made through open competition with no set-aside designation, reflecting the contractor's...
- The Defense Logistics Agency awarded a $5,818.60 delivery order to AmerisourceBergen Drug Corp on May 6, 2025, for the supply of Bridion 200 mg/2 mL vials. The contract, which is not set-aside and carries a firm fixed price, will be fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania location, with an ultimate completion date of May 7, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a $49,205.91 delivery order to AmerisourceBergen Drug Corp on October 8, 2025, for the supply of Bridion 500 mg/5 mL vials. The contract is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of October 9, 2025, and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. This award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a $39,774.31 firm fixed-price delivery order to AmerisourceBergen Drug Corp on June 20, 2025, for the supply of Bridion 500 mg/5 mL vials. The contract represents a non-competitive delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime vehicle serves as a comprehensive global pharmaceutical support contract enabling...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Bridion 200 mg/2 ml vials, valued at $13,599.02 under firm fixed price terms. The award was made on August 18, 2025, with an ultimate completion date of August 19, 2025, and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $3,070.80 to AmerisourceBergen Drug Corp for the supply of Bridion 500 mg/5 mL vials on July 18, 2025, with an ultimate completion date of July 21, 2025. This competitive award utilizes firm fixed pricing with no set-aside designation and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $22,659.00 delivery order to AmerisourceBergen Drug Corp for Bridion 200 mg/2 mL vials on September 3, 2025, with completion scheduled for September 4, 2025. This firm fixed-price, competitively awarded contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The contract carries no set-aside designation and will be performed at...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on July 21, 2025, for the supply of Bridion 200mg/2ml (10 units) with a ceiling value of $24,536.83. This firm fixed-price, competitively awarded delivery order is funded by the Defense Logistics Agency's Medical Supply Chain division and is scheduled for completion by August 15, 2025. The contract represents a child order under AmerisourceBergen's larger...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FHD28Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 27, 2025, for the supply of Bridion 200 mg/2 ml vials with a ceiling value of $13,804.03. This firm fixed-price delivery order, which is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00 through December 2026, was competitively awarded with no set-aside designation. Performance of the order is to be fulfilled from the company's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement vendor that supplies a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare systems. The company's extensive portfolio under its DLA Troop Support Medical contract covers diverse therapeutic domains including specialty medications, brand-name and generic drugs, vaccines, and medical supplies. This specific delivery order for Bridion, a neuromuscular reversal agent used in anesthesia, reflects the company's role in supplying specialized pharmaceutical commodities to support Defense Health Agency operations and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.8k | 5/27/25 |